Invited Speakers

Giacomo Indiveri is Professor of Neuromorphic Cognitive Systems at the University of Zurich and ETH Zurich. He holds an MSc in electrical engineering and a PhD in computer science. His interests lie in the design of mixed-signal neuromorphic electronic systems and learning circuits. His group uses these neuromorphic circuits to validate brain-inspired computational paradigms in real-world scenarios and to develop a new generation of fault-tolerant event-based neuromorphic computing technologies. Indiveri is the senior member of the IEEE society and a recipient of the 2021 IEEE Biomedical Circuits and Systems Best Paper Award. He is also an ERC fellow, receiving three European Research Council grants.

Adele Barnard combines a PhD in Immunology with almost 20 years of experience in neuromodulation, having contributed to the development of some of the earliest waveforms and IPG systems in the mid-2000s. With extensive expertise in managing clinical trials in both the medical device and pharmacology sectors, she has led clinical research across Australia and held executive roles in prominent US companies, including Nevro and Abbott. Currently, Adele heads up a portfolio of clinical trials at Veritus Research in Australia. She also serves on human research ethics boards for medical device studies and consults to biotech companies, providing insights into the Australian regulatory landscape.

Lindsey Jardine is a senior-level clinical and regulatory consultant specializing in novel Class III neurotechnology. She has guided multiple Breakthrough Designation devices through FDA pathways, from early feasibility to pivotal trials, with a current focus on first-in-human studies and closed-loop stimulation systems. With a background spanning startups and cross-functional teams, Lindsey is known for aligning regulatory, clinical, and business goals into cohesive strategies that accelerate development without compromising rigor. Her work centers on helping teams navigate ambiguity. Whether it’s shaping trial design, building evidence frameworks, or translating innovative tech into meaningful patient outcomes. She’s looking forward to this panel discussion on regulated neurotech, and to sharing practical insights from the field where strategy meets execution.

JoJo Platt is a recognized leader in the neurotechnology and medtech ecosystems, known for her ability to bridge the gap between research, commercialization, and investment. With years of experience facilitating collaborations between scientists, engineers, and investors, she has played a pivotal role in advancing innovative technologies from concept to market. Her expertise spans neuromodulation, bioelectronic medicine, and early-stage startup strategy, making her an invaluable resource for companies seeking guidance in funding, partnerships, and market positioning​. JoJo has worked alongside some of the foremost pioneers in neurotech, advocating for scientific rigor, industry growth, and patient-centric innovation​. Startups looking to navigate the complexities of fundraising, product development, and regulatory landscapes benefit from JoJo’s deep understanding of the medtech ecosystem. Her extensive network includes venture capitalists, angel investors, and key opinion leaders who help shape the future of healthcare innovation​. As a frequent speaker and panel moderator at global conferences, she brings fresh insights into how emerging technologies can successfully transition from academic research to real-world impact. Whether it’s developing commercialization strategies, refining investor pitches, or fostering meaningful collaborations, JoJo’s strategic acumen makes her a trusted advisor for entrepreneurs looking to transform bold ideas into tangible solutions​.